Tissue Diagnostics Market Trends and Forecast (2021-2031)
The Tissue Diagnostics Market is expected to register a CAGR of 8.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product (Consumables, and Instruments). The report is segmented by Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining). The report is segmented by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Other Diseases). The report is segmented by End User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Tissue Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Tissue Diagnostics Market Segmentation
Product- Consumables
- Instruments
- Immunohistochemistry
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Strategic Insights
Tissue Diagnostics Market Growth Drivers- Growing Incidences of Chronic Diseases: One of the major market growth drivers in the tissue diagnostics industry is the growing incidence of chronic diseases, especially cancer. As per World Health Organization, there are some deaths caused due to cancer in the world. With an aging world population, the incidence of chronic diseases, including cancer, will steadily increase; therefore, the demand for advanced diagnostic tools that are more precise and occur earlier will significantly increase. Tissue diagnostics is also increasingly implemented in cancer detection because it enables pathologists to differentiate various types of tumors and stages of cancers for positive decisions.
- Advances in diagnostic technology: This is due to continually emerging diagnostic technologies that change the face of tissue diagnostics. For example, next-generation sequencing (NGS), molecular diagnostics, and digital pathology have ensured diseases are diagnosed accurately, rapidly, and non-invasively. An example in this regard is how digital pathology allows for remote conferencing for pathologists while examining high-resolution digital images of tissue samples. Improved accuracy comes with a likelihood of more personalized treatments hence further pushing the market.
- Growth in Personalized Medicine: Another leading factor increasing the demand for tissue diagnostics is the growth in personalized medicine. Personalized medicine is that form of treatment that is tailored according to the genetic makeup of an individual. Personalized medicine requires very accurate molecular and genetic examination of tissue samples. The growing interest in precision medicine provides a growing need for sophisticated diagnostic equipment in the tissue diagnostics arena. It enables the evaluation of particular mutations or biomarkers in cancerous tissues and enhances treatment choice and patient results while minimizing unnecessary treatments.
- Technological Advancements in Diagnostic Tools: Increasing the high-tech diagnostic tools and techniques has constantly been changing the face of tissue diagnostics. Techniques such as next-generation sequencing, molecular diagnostics, and digital pathology can increase precision, speed, and less invasiveness in making a diagnosis. This allows pathologists to see digital images of tissue specimens at high-resolution levels, thus reducing the complexity of the process and fostering e-consultation among specialists. All these advances are expected to make diagnoses more accurate and lead to more targeted treatments, so yet again, the market will be spurred forward.
- Increasing Demand for Personalized Medicine: Another major growth driver of the tissue diagnostics market is the adoption of personalized medicine. In the field of personalized medicine, tissue diagnostics is usually dependent on the very precise molecular and genetic analysis of tissue samples. It is very apparent that advanced tissue diagnostics would be in high demand with the progress of precision medicine. The evaluation of tumor tissues for specific biomarkers or mutations aids clinicians in making a better choice regarding most appropriate therapies and would also reduce unnecessary treatment, hence healthy patient outcomes.
- Healthcare Spending and Research Funding: Around the world, governments and healthcare organizations are investing heavily in healthcare infrastructure and research, especially in oncology and disease diagnosis. This investment culminates in better and newer diagnostic tools and technologies as well as more tissue diagnostics for emerging markets. As the healthcare systems continue to modernize and become disease preventive in nature, the need for tissue diagnostics continues to grow due to the increasing need to offer a better solution for the detection and management of diseases.
- Progression in Discovery of Biomarkers and its Subsequent Developments: The process and finding new markers for measuring different diseases, more so cancers, is a very big call for the players in the tissue diagnosis business. As the scientists discover more specific markers for a diagnosis, test for them will surely improve, in which ways will diagnose earlier, provide the prognosis more accurately and most importantly treatment will be more of targeted therapy. This paves way for new products and services as far as diagnosis is concerned.
- The Rise of Collaborations, Mergers and Acquisitions: Collaboration amongst researchers from universities, innovative biotech organizations and drug research companies provides an opportunity to speed up the development of more advanced tissue diagnostic methods. It is these combinations that cross such frontiers creating advances in tissue diagnostics, especially where molecular and genetic assays for disease are concerned, and enhancement of treatment accuracy.
- Government Policies and Supportive Regulatory Framework: Advanced Maternal Age Reproductive Health Treatment in most countries, this policy and secondary policies are aimed at very efficient use of healthcare system with cost saving and cost containment. In this regard implementation of such advanced tissue diagnostic services is likely to remove the barriers to entry that the present and potential market players in tissue diagnostics may be facing.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Tissue Diagnostics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Tissue Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are Thermo Fisher Scientific, Danaher, Becton, Dickinson, and Company, Agilent Technologies, Abbott, Roche, Merck KGaA, Biogenex, Hologic Inc., Qiagen
Consumables segment, by product, dominated the market in 2023.
North America region dominated the Tissue Diagnostics market in 2023.
Progression in Discovery of Biomarkers and its Subsequent Developments act as a opportunity for growth of the market in forecast period.
The Tissue Diagnostics Market is estimated to witness a CAGR of 8.5% from 202#to 2031
The major factors driving the Tissue Diagnostics market are:
1. Advances in diagnostic technology
2. Growth in Personalized Medicine
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tissue Diagnostics Market - By Product
1.3.2 Tissue Diagnostics Market - By Technology
1.3.3 Tissue Diagnostics Market - By Disease
1.3.4 Tissue Diagnostics Market - By End User
1.3.5 Tissue Diagnostics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TISSUE DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TISSUE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TISSUE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. TISSUE DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. TISSUE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TISSUE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.3.3. Antibodies Market
7.3.3.1. Overview
7.3.3.2. Antibodies Market Forecast and Analysis
7.3.4. Kits Market
7.3.4.1. Overview
7.3.4.2. Kits Market Forecast and Analysis
7.3.5. Reagents Market
7.3.5.1. Overview
7.3.5.2. Reagents Market Forecast and Analysis
7.3.6. Probes Market
7.3.6.1. Overview
7.3.6.2. Probes Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.4.3. Slide Staining System Market
7.4.3.1. Overview
7.4.3.2. Slide Staining System Market Forecast and Analysis
7.4.4. Scanner Market
7.4.4.1. Overview
7.4.4.2. Scanner Market Forecast and Analysis
7.4.5. Tissue Processing system Market
7.4.5.1. Overview
7.4.5.2. Tissue Processing system Market Forecast and Analysis
7.4.6. Other instruments Market
7.4.6.1. Overview
7.4.6.2. Other instruments Market Forecast and Analysis
8. TISSUE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOHISTOCHEMISTRY (IHC)
8.3.1. Overview
8.3.2. Immunohistochemistry (IHC) Market Forecast and Analysis
8.4. IN SITU HYBRIDIZATION (ISH)
8.4.1. Overview
8.4.2. In Situ Hybridization (ISH) Market Forecast and Analysis
8.5. DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT
8.5.1. Overview
8.5.2. Digital Pathology and Workflow Management Market Forecast and Analysis
8.6. SPECIAL STAINING
8.6.1. Overview
8.6.2. Special Staining Market Forecast and Analysis
9. TISSUE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
9.1. OVERVIEW
9.2. DISEASE MARKET FORECASTS AND ANALYSIS
9.3. BREAST CANCER
9.3.1. Overview
9.3.2. Breast Cancer Market Forecast and Analysis
9.4. GASTRIC CANCER
9.4.1. Overview
9.4.2. Gastric Cancer Market Forecast and Analysis
9.5. LYMPHOMA
9.5.1. Overview
9.5.2. Lymphoma Market Forecast and Analysis
9.6. PROSTATE CANCER
9.6.1. Overview
9.6.2. Prostate Cancer Market Forecast and Analysis
9.7. NON-SMALL CELL LUNG CANCER (NSCLC)
9.7.1. Overview
9.7.2. Non-Small Cell Lung Cancer (NSCLC) Market Forecast and Analysis
9.8. OTHER DISEASES
9.8.1. Overview
9.8.2. Other Diseases Market Forecast and Analysis
10. TISSUE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. RESEARCH LABORATORIES
10.4.1. Overview
10.4.2. Research Laboratories Market Forecast and Analysis
10.5. PHARMACEUTICAL COMPANIES
10.5.1. Overview
10.5.2. Pharmaceutical Companies Market Forecast and Analysis
10.6. CONTRACT RESEARCH ORGANIZATIONS
10.6.1. Overview
10.6.2. Contract Research Organizations Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. TISSUE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Tissue Diagnostics Market Overview
11.1.2 North America Tissue Diagnostics Market Forecasts and Analysis
11.1.3 North America Tissue Diagnostics Market Forecasts and Analysis - By Product
11.1.4 North America Tissue Diagnostics Market Forecasts and Analysis - By Technology
11.1.5 North America Tissue Diagnostics Market Forecasts and Analysis - By Disease
11.1.6 North America Tissue Diagnostics Market Forecasts and Analysis - By End User
11.1.7 North America Tissue Diagnostics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Tissue Diagnostics Market
11.1.7.1.1 United States Tissue Diagnostics Market by Product
11.1.7.1.2 United States Tissue Diagnostics Market by Technology
11.1.7.1.3 United States Tissue Diagnostics Market by Disease
11.1.7.1.4 United States Tissue Diagnostics Market by End User
11.1.7.2 Canada Tissue Diagnostics Market
11.1.7.2.1 Canada Tissue Diagnostics Market by Product
11.1.7.2.2 Canada Tissue Diagnostics Market by Technology
11.1.7.2.3 Canada Tissue Diagnostics Market by Disease
11.1.7.2.4 Canada Tissue Diagnostics Market by End User
11.1.7.3 Mexico Tissue Diagnostics Market
11.1.7.3.1 Mexico Tissue Diagnostics Market by Product
11.1.7.3.2 Mexico Tissue Diagnostics Market by Technology
11.1.7.3.3 Mexico Tissue Diagnostics Market by Disease
11.1.7.3.4 Mexico Tissue Diagnostics Market by End User
11.2. EUROPE
11.2.1 Europe Tissue Diagnostics Market Overview
11.2.2 Europe Tissue Diagnostics Market Forecasts and Analysis
11.2.3 Europe Tissue Diagnostics Market Forecasts and Analysis - By Product
11.2.4 Europe Tissue Diagnostics Market Forecasts and Analysis - By Technology
11.2.5 Europe Tissue Diagnostics Market Forecasts and Analysis - By Disease
11.2.6 Europe Tissue Diagnostics Market Forecasts and Analysis - By End User
11.2.7 Europe Tissue Diagnostics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Tissue Diagnostics Market
11.2.7.1.1 Germany Tissue Diagnostics Market by Product
11.2.7.1.2 Germany Tissue Diagnostics Market by Technology
11.2.7.1.3 Germany Tissue Diagnostics Market by Disease
11.2.7.1.4 Germany Tissue Diagnostics Market by End User
11.2.7.2 France Tissue Diagnostics Market
11.2.7.2.1 France Tissue Diagnostics Market by Product
11.2.7.2.2 France Tissue Diagnostics Market by Technology
11.2.7.2.3 France Tissue Diagnostics Market by Disease
11.2.7.2.4 France Tissue Diagnostics Market by End User
11.2.7.3 Italy Tissue Diagnostics Market
11.2.7.3.1 Italy Tissue Diagnostics Market by Product
11.2.7.3.2 Italy Tissue Diagnostics Market by Technology
11.2.7.3.3 Italy Tissue Diagnostics Market by Disease
11.2.7.3.4 Italy Tissue Diagnostics Market by End User
11.2.7.4 Spain Tissue Diagnostics Market
11.2.7.4.1 Spain Tissue Diagnostics Market by Product
11.2.7.4.2 Spain Tissue Diagnostics Market by Technology
11.2.7.4.3 Spain Tissue Diagnostics Market by Disease
11.2.7.4.4 Spain Tissue Diagnostics Market by End User
11.2.7.5 United Kingdom Tissue Diagnostics Market
11.2.7.5.1 United Kingdom Tissue Diagnostics Market by Product
11.2.7.5.2 United Kingdom Tissue Diagnostics Market by Technology
11.2.7.5.3 United Kingdom Tissue Diagnostics Market by Disease
11.2.7.5.4 United Kingdom Tissue Diagnostics Market by End User
11.2.7.6 Rest of Europe Tissue Diagnostics Market
11.2.7.6.1 Rest of Europe Tissue Diagnostics Market by Product
11.2.7.6.2 Rest of Europe Tissue Diagnostics Market by Technology
11.2.7.6.3 Rest of Europe Tissue Diagnostics Market by Disease
11.2.7.6.4 Rest of Europe Tissue Diagnostics Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Tissue Diagnostics Market Overview
11.3.2 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis
11.3.3 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis - By Disease
11.3.6 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Tissue Diagnostics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Tissue Diagnostics Market
11.3.7.1.1 Australia Tissue Diagnostics Market by Product
11.3.7.1.2 Australia Tissue Diagnostics Market by Technology
11.3.7.1.3 Australia Tissue Diagnostics Market by Disease
11.3.7.1.4 Australia Tissue Diagnostics Market by End User
11.3.7.2 China Tissue Diagnostics Market
11.3.7.2.1 China Tissue Diagnostics Market by Product
11.3.7.2.2 China Tissue Diagnostics Market by Technology
11.3.7.2.3 China Tissue Diagnostics Market by Disease
11.3.7.2.4 China Tissue Diagnostics Market by End User
11.3.7.3 India Tissue Diagnostics Market
11.3.7.3.1 India Tissue Diagnostics Market by Product
11.3.7.3.2 India Tissue Diagnostics Market by Technology
11.3.7.3.3 India Tissue Diagnostics Market by Disease
11.3.7.3.4 India Tissue Diagnostics Market by End User
11.3.7.4 Japan Tissue Diagnostics Market
11.3.7.4.1 Japan Tissue Diagnostics Market by Product
11.3.7.4.2 Japan Tissue Diagnostics Market by Technology
11.3.7.4.3 Japan Tissue Diagnostics Market by Disease
11.3.7.4.4 Japan Tissue Diagnostics Market by End User
11.3.7.5 South Korea Tissue Diagnostics Market
11.3.7.5.1 South Korea Tissue Diagnostics Market by Product
11.3.7.5.2 South Korea Tissue Diagnostics Market by Technology
11.3.7.5.3 South Korea Tissue Diagnostics Market by Disease
11.3.7.5.4 South Korea Tissue Diagnostics Market by End User
11.3.7.6 Rest of Asia-Pacific Tissue Diagnostics Market
11.3.7.6.1 Rest of Asia-Pacific Tissue Diagnostics Market by Product
11.3.7.6.2 Rest of Asia-Pacific Tissue Diagnostics Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Tissue Diagnostics Market by Disease
11.3.7.6.4 Rest of Asia-Pacific Tissue Diagnostics Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Tissue Diagnostics Market Overview
11.4.2 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis
11.4.3 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis - By Disease
11.4.6 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Tissue Diagnostics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Tissue Diagnostics Market
11.4.7.1.1 South Africa Tissue Diagnostics Market by Product
11.4.7.1.2 South Africa Tissue Diagnostics Market by Technology
11.4.7.1.3 South Africa Tissue Diagnostics Market by Disease
11.4.7.1.4 South Africa Tissue Diagnostics Market by End User
11.4.7.2 Saudi Arabia Tissue Diagnostics Market
11.4.7.2.1 Saudi Arabia Tissue Diagnostics Market by Product
11.4.7.2.2 Saudi Arabia Tissue Diagnostics Market by Technology
11.4.7.2.3 Saudi Arabia Tissue Diagnostics Market by Disease
11.4.7.2.4 Saudi Arabia Tissue Diagnostics Market by End User
11.4.7.3 U.A.E Tissue Diagnostics Market
11.4.7.3.1 U.A.E Tissue Diagnostics Market by Product
11.4.7.3.2 U.A.E Tissue Diagnostics Market by Technology
11.4.7.3.3 U.A.E Tissue Diagnostics Market by Disease
11.4.7.3.4 U.A.E Tissue Diagnostics Market by End User
11.4.7.4 Rest of Middle East and Africa Tissue Diagnostics Market
11.4.7.4.1 Rest of Middle East and Africa Tissue Diagnostics Market by Product
11.4.7.4.2 Rest of Middle East and Africa Tissue Diagnostics Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Tissue Diagnostics Market by Disease
11.4.7.4.4 Rest of Middle East and Africa Tissue Diagnostics Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Tissue Diagnostics Market Overview
11.5.2 South and Central America Tissue Diagnostics Market Forecasts and Analysis
11.5.3 South and Central America Tissue Diagnostics Market Forecasts and Analysis - By Product
11.5.4 South and Central America Tissue Diagnostics Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Tissue Diagnostics Market Forecasts and Analysis - By Disease
11.5.6 South and Central America Tissue Diagnostics Market Forecasts and Analysis - By End User
11.5.7 South and Central America Tissue Diagnostics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Tissue Diagnostics Market
11.5.7.1.1 Brazil Tissue Diagnostics Market by Product
11.5.7.1.2 Brazil Tissue Diagnostics Market by Technology
11.5.7.1.3 Brazil Tissue Diagnostics Market by Disease
11.5.7.1.4 Brazil Tissue Diagnostics Market by End User
11.5.7.2 Argentina Tissue Diagnostics Market
11.5.7.2.1 Argentina Tissue Diagnostics Market by Product
11.5.7.2.2 Argentina Tissue Diagnostics Market by Technology
11.5.7.2.3 Argentina Tissue Diagnostics Market by Disease
11.5.7.2.4 Argentina Tissue Diagnostics Market by End User
11.5.7.3 Rest of South and Central America Tissue Diagnostics Market
11.5.7.3.1 Rest of South and Central America Tissue Diagnostics Market by Product
11.5.7.3.2 Rest of South and Central America Tissue Diagnostics Market by Technology
11.5.7.3.3 Rest of South and Central America Tissue Diagnostics Market by Disease
11.5.7.3.4 Rest of South and Central America Tissue Diagnostics Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TISSUE DIAGNOSTICS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. TISSUE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. DANAHER
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BECTON, DICKINSON, AND COMPANY
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. AGILENT TECHNOLOGIES
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ABBOTT
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. ROCHE
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MERCK KGAA
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. BIOGENEX
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. HOLOGIC INC.,
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ABCAM
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
- Thermo Fisher Scientific
- Danaher
- Becton, Dickinson, and Company
- Agilent Technologies
- Abbott
- Roche
- Merck KGaA
- Biogenex
- Hologic Inc.
- Qiagen
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For